Search

Your search keyword '"Brenner, Malcolm K."' showing total 1,731 results

Search Constraints

Start Over You searched for: Author "Brenner, Malcolm K." Remove constraint Author: "Brenner, Malcolm K."
1,731 results on '"Brenner, Malcolm K."'

Search Results

201. Engineered off-the-shelf therapeutic T cells resist host immune rejection

202. Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4 + T cells

203. Reduced Autoimmune Cytopenias after Cord Blood Transplant in Pediatric Patients with Nonmalignant Disease Conditioned without Serotherapy

204. Excellent Engraftment with Reduced Treatment Related Mortality for Young Pediatric Patients Using Umbilical Cord Blood Transplantation (UCBT) Conditioned without Serotherapy

205. CD5 CAR T-Cells for Treatment of Patients with Relapsed/Refractory CD5 Expressing T-Cell Lymphoma Demonstrates Safety and Anti-Tumor Activity

213. Retinoblastoma Treatment

226. Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma

229. 281 - Safety and Tolerability of Administering Leukemia-Specific Donor T Cells (mLSTs) after Allogeneic Transplant to Pediatric Patients with AML/MDS

230. 245 - Long Term Follow up for the Development of Subsequent Malignancies in Patients Treated with Genetically Modified Immune Effectors

232. 26 - Evaluating the Safety and Clinical Efficacy of Off-the-Shelf CD30.CAR-Modified Epstein-Barr Virus-Specific T Cells in Patients with CD30-Positive Lymphoma

233. T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells

236. Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed/Refractory T-Cell Malignancies

237. Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

241. CD30-Chimeric Antigen Receptor (CAR) T Cells for Therapy of Hodgkin Lymphoma (HL)

243. Excellent Outcomes for Pediatric Non-Malignant Diseases Using Umbilical Cord Blood Transplantation (UCBT) Conditioned without Serotherapy in the Absence of a Matched Related Donor

244. Targeting Lymphomas Using Non-Engineered, Multi-Antigen-Specific T Cells

245. Safety and Efficacy of Multiantigen-Targeted T Cells for Multiple Myeloma

246. Administering Leukemia-Directed Donor Lymphocytes to Patients with AML or MDS to Prevent or Treat Post-Allogeneic HSCT Relapse

248. CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia

Catalog

Books, media, physical & digital resources